WHO guideline development of paediatric medicines: points to consider in pharmaceutical development

scientific article published on 01 October 2012

WHO guideline development of paediatric medicines: points to consider in pharmaceutical development is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.IJPHARM.2012.05.054
P698PubMed publication ID22883696

P2093author name stringHenning G Kristensen
P433issue2
P304page(s)134-135
P577publication date2012-10-01
P1433published inInternational Journal of PharmaceuticsQ6051539
P1476titleWHO guideline development of paediatric medicines: points to consider in pharmaceutical development
P478volume435

Reverse relations

cites work (P2860)
Q35977237Development of taste masked caffeine citrate formulations utilizing hot melt extrusion technology and in vitro-in vivo evaluations
Q92480898Dosage form preference consultation study in children and young adults: paving the way for patient-centred and patient-informed dosage form development
Q36906179Essential medicines containing ethanol elevate blood acetaldehyde concentrations in neonates.
Q93187087Pediatric Oral Formulations: An Updated Review of Commercially Available Pediatric Oral Formulations Since 2007
Q48505848Quantification of theophylline or paracetamol in milk matrices by high-performance liquid chromatography
Q28079594Safe and effective pharmacotherapy in infants and preschool children: importance of formulation aspects

Search more.